Researchers, including Aaron Scott, MD, associate professor of medicine, modified the chemotherapy drug paclitaxel to more effectively target breast and pancreatic cancer tumors.

A study recently published in Nature describes a “previously unrecognized” sense that facilitates communication between the gut and the brain.

A new study led by Dr. Stefano Guerra, professor of medicine, will investigate whether levels of the lung protein CC16 in childhood can predict risk of early chronic obstructive pulmonary disease later in life.

A U of A Cancer Center team led by the Division of Hematology & Oncology’s Drs. Steffan Nawrocki and Jennifer Carew identified a novel biomarker to predict which patients with clear cell renal cell carcinoma may best benefit from a targeted combination therapy involving autophagy inhibition.

Researchers will take a precision medicine approach to treating obstructive sleep apnea in people with Down syndrome.

Researchers found a two-way relationship between some vitamin and mineral deficiencies and chronic pain, which could lead to personalized treatments.

The Division of Infectious Diseases and Valley Fever Center for Excellence physician-scientist is on the front line in the fight for her patients and to bring increased attention to the fungal disease.

A new paper published in Nature provides insights into why men with loss of Y have increased cancer risks and poorer outcomes.

Vaccinated people generated an overall protective immune response to the Delta and Omicron strains of COVID-19, though with slightly fewer antibodies for the mutated parts of the virus.

Research at the U of A is giving hope to people with Parkinson’s disease.